These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 11366790)

  • 1. Are changes in body shape due to drug side effects?
    TreatmentUpdate; 1999 Jun; 11(4):3-4. PubMed ID: 11366790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are changes in body shape linked to viral load.
    TreatmentUpdate; 1999 Jun; 11(4):4-5. PubMed ID: 11366791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fat, sugar and drugs on the French Riviera.
    Lands L
    GMHC Treat Issues; 1999 Mar; 13(3):9-11. PubMed ID: 11366205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipodrama.
    Horn T
    Res Initiat Treat Action; 1999 Dec; 5(5):13-5. PubMed ID: 11366885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Increased girth, thin arms. Unusual changes in HIV therapy].
    MMW Fortschr Med; 1999 Sep; 141(36):62-3. PubMed ID: 10904607
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lipodystrophy and metabolic disorders in anti-HIV therapy].
    Behrens GM; Stoll M; Schmidt RE
    MMW Fortschr Med; 2000 Mar; 142 Suppl 1():68-71. PubMed ID: 10863318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse drug reactions to protease inhibitors.
    Manchanda T; Schiedel D; Fischer D; Dekaban GA; Rieder MJ
    Can J Clin Pharmacol; 2002; 9(3):137-46. PubMed ID: 12422251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facial and limb fat loss: lipoatrophy.
    Proj Inf Perspect; 2003 Oct; (36):11-2. PubMed ID: 14696569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit of switching from a protease inhibitor (PI) to nevirapine in PI-experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL): interim analysis at 3 months of follow-up.
    Negredo E; Paredes R; Bonjoch A; Tuldrà A; Fumaz CR; Gel S; Garcés B; Johnston S; Arnó A; Balagué M; Jou A; Tural C; Sirera G; Romeu J; Cruz L; Francia E; Domingo P; Arrizabalaga J; Ruiz I; Arribas JR; Ruiz L; Clotet B
    Antivir Ther; 1999; 4 Suppl 3():23-8. PubMed ID: 16021868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity of antiretroviral therapy and implications for drug development.
    Carr A
    Nat Rev Drug Discov; 2003 Aug; 2(8):624-34. PubMed ID: 12904812
    [No Abstract]   [Full Text] [Related]  

  • 11. Transfer therapy--Nevirapine for protease problems?
    TreatmentUpdate; 1999 Jun; 11(4):6-7. PubMed ID: 11366793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protease inhibitors and body shape changes.
    TreatmentUpdate; 1998 Apr; 10(2):4-5. PubMed ID: 11365437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New antiretroviral drugs part I: PIs.
    Murphy RL
    AIDS Clin Care; 1999 May; 11(5):35-7. PubMed ID: 11367101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipodystrophy in patients with HIV-1 infection: effect of stopping protease inhibitors on TNF-alpha and TNF-receptor levels, and on metabolic parameters.
    Maher B; Lloyd J; Wilkins EG; Fraser WD; Back D; Park BK; Pirmohamed M
    Antivir Ther; 2004 Dec; 9(6):879-87. PubMed ID: 15651746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting body shape changes.
    TreatmentUpdate; 2002 Nov; 14(8):7. PubMed ID: 12501828
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in body shape and metabolic abnormalities.
    Res Initiat Treat Action; 1999 Jan; 5(1):18. PubMed ID: 11366225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of antiretroviral triple combinations including the protease inhibitor nelfinavir in heavily pretreated children with HIV-1 infection.
    Hoffmann F; Funk M; Linde R; Notheis G; Petropoulou T; Eberle J; Gürtler L; Belohradsky BH; Wintergerst U
    Eur J Med Res; 2002 Jul; 7(7):330-4. PubMed ID: 12176683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body changes and blood abnormalities: the lipodystrophy and fat redistribution conundrum.
    Martinez LJ
    Res Initiat Treat Action; 1999 Apr; 5(2):22-5. PubMed ID: 11366281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HAL in 2001: a fat oddity.
    Grinberg L; Torres G
    GMHC Treat Issues; 1999 Mar; 13(3):2-5, 8. PubMed ID: 11366203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.